(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.

Fig. 6. Fgf17 inhibits development of outer hair cells and Deiters cells.
(A,B) Low-magnification view of p75ntr expression
(red) in (A) a control explant and (B) in an explant treated with 300 ng/ml
Fgf17 for 5 days. (C) High-magnification of a control OC. Cell surfaces
and stereocilia are labeled with phalloidin (green),
p75ntr-positive PCs in red. (D) High magnification of an
Fgf17-treated explant. IHCs are present, but the OHC region appears
undifferentiated and is positive for p75ntr (red).
(E-F') Lumenal views of the OC from E14 mouse cochlear explants
after 6 DIV. (E) PCs, positive for both p75ntr (green) and
ß-actin (red), appear as a yellow line between IHCs and OHCs [myosin VI
(Myo6) in blue]. (E') ß-actin alone. (F) OHC numbers are reduced
and p75ntr expression is increased (green) in the OHC region in
Fgf17-treated explants. At the extreme lateral edge, a second band of
ß-actin expression (red in F, arrow) appears. (F') ß-actin
alone. (G) An Fgf17-treated explant with few OHCs (numbered). Most
cells in the OHC region are positive for p75ntr (red).
(G') p75ntr expression alone. OHC positions are
indicated with numbered circles. (H-I') High magnification of
individual examples of OHCs from Fgf17-treated explants. Stereocilia and cell
boundaries are indicated in green, p75ntr in red. Asterisks in
G-I' indicate cells adjacent to OHCs that have downregulated expression
of p75ntr. Scale bars: 200 µm in A,B; 50 µm in C,D; 20 µm
in E-F'; 25 µm in G,G'; 20 µm in H-I'.